TED.L Regulatory News (TED)

13 Sep 2005 16:19

Tepnel Life Sciences PLC13 September 2005 13 September 2005 Tepnel Life Sciences plc ('the Company') Holding in Company The Company received notification on 13 September 2005 that, following recentpurchases, Mr. J M Harvey has a notifiable interest in 9,441,909 ordinary sharesof 1p each in the Company representing approximately 4.43 per cent of the issuedshare capital. About Tepnel Tepnel Life Sciences (TLS) is a UK based international biotechnology company.The Company has laboratories, manufacturing and operations in the USA, UK andFrance with 175 employees. TLS provides test kits, reagents and services to twohighly synergistic markets, these being Molecular Diagnostics and BiomedicalResearch. The company's strategy has been to identify high growth nicheopportunities within these multi-billion pound markets. TLS focuses on theseniche opportunities with internally developed products, patents, expertise andknow-how as well as strategic acquisitions, to develop a leadership positionwithin these defined market segments. Enquiries: Ben Matzilevich, Chief Executive Officer, Tepnel Life Sciences plc 0161 946 2200Gron Ffoulkes-Davies, Finance Director, Tepnel Life Sciences plc 0161 946 2200Mark Percy, Seymour Pierce Limited 0207 107 8000Richard Anderson, De Facto Communications Ltd 0207 940 1000 This information is provided by RNS The company news service from the London Stock Exchange